360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Dynavax Technologies Corp

Type: Company

Name: Dynavax Technologies Corp

Nationality: United States

Web Address: http://www.dynavax.com/

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Warner Chilcott plc

StockCall Early Morning Insight into WCRX, DVAX, ISIS, ACT, and AVNR

NASDAQ:WCRX / NASDAQ:DVAX / NASDAQ:ISIS / NYSE:ACT05/15/2013 [ACCESSWIRE]StockCall.com Provides Stock Research on Warner Chilcott plc, Dynavax Technologies Corp., Isis Pharmaceuticals Inc., Actavis Inc., and Avanir Pharmaceuticals.New York City, New York ... [Published BayStreet.ca - May 15 2013]

Entities: Stocks, Warner Chilcott plc, AVANIR Pharmaceuticals, Dynavax Technologies Corp

First reported May 13 2013 - Updated May 13 2013 - 1 reports

NXP Semiconductors NV

See What These $15 Billion Managers Have Been Buying

Keep track of the stocks that matter to you.Help yourself with the Fool's FREE and easy new watchlist service today.Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright ... [Published Motley Fool - May 13 2013]

Entities: watchlist, NXP Semiconductors NV, Vertex Pharmaceuticals Inc, AbbVie

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Incorporated (VRTX): What You Need To Know

What’s the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest. Some take what we at the Fool call a “motley approach” and try a little bit of everything. Others really don’t have an investment ... [Published InsiderMonkey.com - May 13 2013]

Entities: Vertex Pharmaceuticals Inc, Cystic Fibrosis, HEPLISAV, Dynavax Technologies Corp, Drugs

First reported May 06 2013 - Updated May 07 2013 - 2 reports

Dynavax Technologies Corp

Dynavax Technologies Corporation Reports First Quarter 2013 Financial Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!BERKELEY, CA--(Marketwired - May 06, 2013) - Dynavax Technologies Corporation (NASDAQ: DVAX ) today reported financial... ... [Published BioSpace - May 07 2013]

Entities: Dynavax Technologies Corp

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Dynavax Technologies appoints new CEO

Dynavax Technologies Corporation, a biopharmaceutical company, has appointed Eddie Gray as CEO and a member of the company's board. Mr Gray will succeed Dino Dina, M.D., CEO. Dr Dina will remain a consultant to the Company for a transition period and ... [Published Individual.com - May 07 2013]

Entities: Dynavax Technologies Corp, Eddie Gray, Dino Dina

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Dynavax Technologies (DVAX) Releases Quarterly Earnings Results, Hits Estimates

Dynavax Technologies (NASDAQ: DVAX) released its earnings data on Monday. The company reported ($0.11) earnings per share for the quarter, meeting the analysts? consensus estimate of ($0.11), StockRatingsNetwork reports. The company had revenue of $2.10 ... [Published American Banking News - Earnings - May 06 2013]

Entities: Dynavax Technologies Corp, Jefferies Group Inc, Infectious Diseases

First reported May 06 2013 - Updated May 06 2013 - 1 reports

iPad

Dynavax Technologies Corp (DVAX) Reports In-Line Q1 EPS

Dynavax Technologies Corp (NASDAQ: DVAX) reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). For the quarter ended March 31, 2013, Dynavax reported total revenues of $2.1 million compared to $2.4 million for the quarter ended March ... [Published Street Insider - May 06 2013]

Entities: Dynavax Technologies Corp, iPad, iPhone

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Dynavax Reports First Quarter 2013 Financial Results

Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the first quarter ended March 31, 2013. The Company had $105.4 million in cash, cash equivalents and marketable securities as of March 31, 2013. This compared to $125.1 ... [Published NewsBlaze - May 06 2013]

Entities: Dynavax Technologies Corp, adjuvant, Adobe Acrobat, National institutes of Health

First reported Apr 30 2013 - Updated May 01 2013 - 8 reports

Dynavax Technologies Corporation elects Eddie Gray as CEO and board member

5 minutes ago, 8:19am (ET) 05/01/2013 M2Biopharmaceutical company Dynavax Technologies Corporation (NASDAQ:DVAX) said on Tuesday that its board of directors has named Eddie Gray as its chief executive officer and as a member of its board.Effective 1 May ... [Published Zecco - May 01 2013]

Entities: Eddie Gray, Dynavax Technologies Corp, Dino Dina, Elections, HEPLISAV

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Dino Dina out as Dynavax CEO, President Tyler Martin also leaving

CEO Dino Dina and President Tyler Martin, two doctors at the helm of Berkeley's Dynavax Technologies Corp., are both leaving in May.Dynavax (NASDAQ: DVAX) hired Eddie Gray as CEO effective May 1. Gray's most recent job was president of pharmaceuticals ... [Published San Francisco Business Times - Apr 30 2013]

Entities: Dino Dina, Dynavax Technologies Corp, Eddie Gray

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Dynavax Technologies Corp Announces Management Changes

Dynavax Technologies Corp announced that the Company's Board Of Directors has appointed Eddie Gray Chief Executive Officer and a member of Dynavax's board, effective May 1, 2013. Mr. Gray will succeed Dino Dina, M.D., Chief Executive Officer. Dr. Dina ... [Published Reuters - Apr 30 2013]

Entities: Dynavax Technologies Corp, Dino Dina, Eddie Gray

First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

Investors Buzz: Sanofi, Phillips, Dynavax, Albany Molecular

Dallas, TX -- (SBWIRE) -- 04/24/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-Sanofi SA (ADR)(NYSE:SNY) shares jumped ... [Published SBWire - Apr 24 2013]

Entities: Albany Molecular Research Inc, Dynavax Technologies Corp, Sanofi SA

Quotes

...of pharmaceutical industry experience, Eddie has a track record of success in building international commercial organizations," said Dr Dina, CEO. "His extensive executive and operations-based background position him to lead the Company going forward, and he will be a major contributor to driving sustainable long-term value for Dynavax."

Dynavax Technologies appoints new CEO [Published Individual.com - May 07 2013]

...therapeutics are developed, and to address diseases that are not currently reachable by recombinant technologies," Termeer said in a statement. "Moderna shares the same vision, ambition, and potential as many of the early biotechnology leaders. I look forward to helping the company deliver on its vast potential to improve the lives of patients across a wide array of disease areas." Release

Moderna taps biotech legend Henri Termeer for board of directors [Published FierceBiotech - May 03 2013]

Research and Markets has announced the addition of the "" report to their offering. " provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure). Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Chronic Kidney Disease (Chronic Renal Failure). - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Chronic Kidney Disease (Chronic Renal Failure) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. Companies Involved in Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Development - Alexion Pharmaceuticals Inc. - Amgen Inc. - Angion Biomedica Corp. - Ardelyx, Inc. - Astellas Pharma Inc. - AstraZeneca PLC - Bayer AG - Bolder Biotechnology, Inc. - Catabasis Pharmaceuticals, Inc. - Cellmid Ltd - Concert Pharmaceuticals Inc. - CorMedix Inc. - Dynavax Technologies Corporation - Eli Lilly and Company - Evotec Aktiengesellschaft - FibroGen Inc. - Hawthorn Pharmaceuticals Inc. - InVasc Therapeutics, Inc. - Kureha Corporation - La Jolla Pharmaceutical Company - Nile Therapeutics Inc. - Pieris AG - Promedior Inc. - Quark Pharmaceuticals, Inc. - Reata Pharmaceuticals Inc. - Sorbent Therapeutics, Inc. - Stelic Institute & Co. - Thrasos, Inc. - Vicore Pharma AB - Vitae Pharmaceuticals Inc. For more information visit Research and Markets CONTACT: Research and Markets, Laura Wood, Senior Manager. press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Pharmaceuticals (http://www.researchandmarkets.com/categories.asp?cat_id=16&campaign_id=zp8s48)"

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2013 [Published Individual.com - Apr 16 2013]

More Content

sort by: Date \| Relevance
StockCall Early Morning Insight into WCRX, DVAX... [Published BayStreet.ca - May 15 2013]
See What These $15 Billion Managers Have Been B... [Published Motley Fool - May 13 2013]
Vertex Pharmaceuticals Incorporated (VRTX): Wha... [Published InsiderMonkey.com - May 13 2013]
3 Investment Strategy Lessons From Vertex's Suc... [Published Motley Fool - May 11 2013]
Biotech's Next Big Thing: ASCO [Published Oncology Business Review - May 09 2013]
Dynavax Technologies Corporation Reports First ... [Published BioSpace - May 07 2013]
Dynavax Technologies appoints new CEO [Published Individual.com - May 07 2013]
U.S./Canada daily earnings hits & misses May 6 ... [Published Globe and Mail - May 06 2013]
Dynavax Technologies (DVAX) Releases Quarterly ... [Published American Banking News - Earnings - May 06 2013]
Dynavax Reports First Quarter 2013 Financial Re... [Published FinanzNachrichten.de - May 06 2013]
Dynavax Technologies Corp (DVAX) Reports In-Lin... [Published Street Insider - May 06 2013]
National PTA and Discovery Education Join Toget... [Published NewsBlaze - May 06 2013]
Dynavax Reports First Quarter 2013 Financial Re... [Published Marketwire - Breaking News Releases - May 06 2013]
Dynavax Reports First Quarter 2013 Financial Re... [Published NewsBlaze - May 06 2013]
Moderna taps biotech legend Henri Termeer for b... [Published FierceBiotech - May 03 2013]
Dynavax Technologies Corporation elects Eddie G... [Published Zecco - May 01 2013]
Dynavax Technologies Corporation (DVAX) Taps Gl... [Published BioSpace - Apr 30 2013]
Dino Dina out as Dynavax CEO, President Tyler M... [Published San Francisco Business Times - Apr 30 2013]
Dynavax Names CEO [Published Contract Pharma - Apr 30 2013]
Dynavax Technologies Corporation Taps GlaxoSmit... [Published BioSpace - Apr 30 2013]
Dynavax (DVAX) Taps Glaxo's (GSK) Eddie Gray as... [Published Street Insider - Apr 30 2013]
Dynavax Technologies Corp Announces Management ... [Published Reuters - Apr 30 2013]
Dynavax Names Eddie Gray CEO; Meeting Scheduled... [Published RTTNews.com - Apr 30 2013]
Dynavax Names Eddie Gray as Chief Executive Off... [Published Equities.com - Apr 30 2013]
Dynavax Names Eddie Gray as Chief Executive Off... [Published Interest!ALERT - Apr 30 2013]
Dynavax Names Eddie Gray as Chief Executive Off... [Published Marketwire - Breaking News Releases - Apr 30 2013]
Investors Buzz: Sanofi, Phillips, Dynavax, Alba... [Published SBWire - Apr 24 2013]
Report Published: "Lupus Erythematosus - Pipeli... [Published Live-PR.com - Apr 21 2013]
Investors Alert: First Majestic Silver Corp, Dy... [Published SBWire - Apr 19 2013]
Stocks in News: ABIOMED, Dynavax Technologies, ... [Published SBWire - Apr 18 2013]

Blogs

sort by: Date \| Relevance
BIO Career Fair: Impress the best [Published I Am Biotech - Mar 22 2013] Don’t miss an opportunity to spend a day with hiring managers from the nations’ top biotech firms on April 22 at the BIO Career Fair in Chicago. We asked Chanille Hewett, Product Manager for BioSpace , host of the BIO Career Fair, to share some ...
Up And Down The Ladder… Job Changes [Published Pharmalot - Mar 22 2013] Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants ...
Frontrunning: March 4 [Published Zero Hedge - Mar 04 2013] Must defend against Chinese colonial expansion and get the Nigerian oil: U. S. Boosts War Role in Africa ( WSJ ) BOJ nominee Kuroda sets out aggressive policy ideas ( Reuters ) China becomes world’s top oil importer ( FT ) Baby Cured of HIV for the First ...
Global Geophysical Falls Short of Revenue Estim... [Published Wall St. Cheat Sheet - Feb 26 2013] Allied Nevada Gold ( NYSE:ANV ): Closing price $19.62 Allied Nevada Gold reported its fiscal year 2012 earnings at 53 cents, with a consensus of 57 cents. Shares closed up 0.98 percent Monday at $19.62, and have been traded in a 52-week range of $19.19 ...
Pharmalot… Pharmalittle… Good Morning [Published Pharmalot - Feb 26 2013] Rise and shine, everyone, another busy day is on the way. As usual, we are scrambling to get the short people to their schoolhouses and encouraging the official mascots to fertilize the budding weeds as quickly as possible. This takes perseverence and, ...

Press Releases

sort by: Date \| Relevance
Dynavax Reports First Quarter 2013 Financial Re... [Published Marketwire - Breaking News Releases - May 06 2013]
Dynavax Names Eddie Gray as Chief Executive Off... [Published Marketwire - Breaking News Releases - Apr 30 2013]
Dynavax Appoints David Novack as Senior Vice Pr... [Published Marketwire - Breaking News Releases - Mar 21 2013]
Warner Chilcott, Dynavax Technologies, Isis Pha... [Published PR Newswire: Health - Mar 13 2013]
Dynavax Reports Fourth Quarter and Year End 201... [Published Marketwire - Breaking News Releases - Mar 01 2013]